Voice Recognition

MindBio Therapeutics Adds AI-Powered Fatigue Detection to Voice-Based Diagnostics Platform

MindBio Therapeutics Adds AI-Powered Fatigue Detection to Voice-Based Diagnostics Platform

MindBio Therapeutics expands its AI voice diagnostics platform with fatigue recognition technology for high-risk industries, with commercial testing expected in late Q2 2026.

May 11, 2026
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection Amid Growing Real-Time Diagnostics Market

MindBio Therapeutics Advances AI Voice-Based Intoxication Detection Amid Growing Real-Time Diagnostics Market

MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safety, healthcare, and public safety markets as traditional testing methods face limitations.

May 11, 2026
Voice Analysis and AI Could Revolutionize Drug and Alcohol Intoxication Detection

Voice Analysis and AI Could Revolutionize Drug and Alcohol Intoxication Detection

MindBio Therapeutics is developing an AI-powered voice analysis platform to detect real-time impairment from short speech samples, addressing limitations of traditional testing methods.

May 11, 2026
MindBio Therapeutics Files Patents for Voice-Based Intoxication Detection, Targets Mining and Aviation Markets

MindBio Therapeutics Files Patents for Voice-Based Intoxication Detection, Targets Mining and Aviation Markets

MindBio Therapeutics has filed patent applications for an AI-powered voice analysis technology that detects drug and alcohol impairment, with initial deployment in mining and aviation, tapping into a $4.2 billion testing market.

May 7, 2026
MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology

MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology

MindBio Therapeutics has filed patent applications for its AI-driven voice technology that detects drug and alcohol intoxication, with commercial kiosks for mining and aviation on track for delivery by Q2 2026.

April 29, 2026
MindBio Therapeutics Develops AI-Powered Voice Analysis for Non-Invasive Drug and Alcohol Detection

MindBio Therapeutics Develops AI-Powered Voice Analysis for Non-Invasive Drug and Alcohol Detection

MindBio Therapeutics is launching an AI-driven voice analysis technology to detect impairment, targeting a growing $4.2 billion testing market and offering a less invasive alternative to traditional methods.

April 28, 2026
MindBio Therapeutics Moves Toward Commercial Deployment of AI Voice Analysis for Impairment Detection in Mining Sector

MindBio Therapeutics Moves Toward Commercial Deployment of AI Voice Analysis for Impairment Detection in Mining Sector

MindBio Therapeutics appoints Chilean policy expert Felipe Leyton to lead commercialization of its voice-based AI platform for detecting drug and alcohol impairment, starting with South America's mining industry.

April 24, 2026
UST Strategic Investment in aiOla Advances Voice AI Automation for Frontline Operations

UST Strategic Investment in aiOla Advances Voice AI Automation for Frontline Operations

UST's investment in aiOla accelerates the deployment of voice-agentic AI technology that transforms frontline workflows across healthcare, manufacturing, and retail by converting speech into structured data, addressing critical data capture gaps in enterprise operations.

November 4, 2025
Hi Auto Names Crystal Deaderick as Head of Sales to Drive AI Voice Ordering Expansion

Hi Auto Names Crystal Deaderick as Head of Sales to Drive AI Voice Ordering Expansion

Hi Auto's appointment of Crystal Deaderick as Head of Sales signals strategic expansion in the AI voice ordering market as the company addresses growing demand from quick-service restaurants facing labor shortages and customer service challenges.

October 31, 2025